
Pantavin 40mg Injection
Marketer
Vintech Formulations
Salt Composition
Pantoprazole (40mg)
Overview Pantavin 40mg Injection
AcidGard 40mg Injection diminishes gastric acid production. Indicated for acid-related gastrointestinal disorders including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, it alleviates symptoms and facilitates healing. AcidGard 40mg Injection also prevents stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this intravenous medication is administered solely by a healthcare professional when deemed clinically preferable to oral formulations. Dosage is individualized based on patient response and underlying condition, with treatment duration determined by your physician. Consistent adherence to the prescribed regimen is crucial, even with rapid symptom resolution. Lifestyle modifications, such as frequent, smaller meals and avoidance of caffeine, spicy foods, and fatty foods, can enhance treatment effectiveness. Common, typically mild, adverse effects include nausea, vomiting, headache, vertigo, flatulence, diarrhea, abdominal discomfort, and thrombophlebitis. Persistent or bothersome symptoms warrant medical consultation. Prolonged use may elevate the risk of certain side effects; prolonged use exceeding one year may increase bone fracture risk, particularly at higher doses. Discuss bone health maintenance strategies, including calcium and vitamin D supplementation, with your physician. AcidGard 40mg Injection is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or pre-existing osteoporosis. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to its acid-stimulating properties. Refrain from operating machinery or driving if dizziness or drowsiness occurs.
Uses of Pantavin 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pantavin 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Pantavin 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pantavin 40mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Pantavin 40mg Injection works:
Acid reflux and indigestion find relief with Pantavin 40mg Injection, a proton pump inhibitor (PPI) that diminishes gastric acid production.
SAFETY ADVICE
AlcoholUNSAFE
Combining Pantavin 40mg Injection and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Pantavin 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Pantavin 40mg Injection without significant risk to their infants. Available human data indicates minimal danger to the baby.
DrivingCONSULT YOUR DOCTOR
The effect of Pantavin 40mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Pantavin 40mg Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
For patients with severe hepatic impairment, the administration of Pantavin 40mg Injection requires careful consideration. A modified dosage of Pantavin 40mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Pantavin 40mg Injection :
Omitting a scheduled dose of Pantavin 40mg Injection warrants immediate physician consultation.
Facts to Know About Pantavin 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |
